ESLA
Estrella Immunopharma, Inc. - Common Stock (ESLA)
$88
About Estrella Immunopharma, Inc. - Common Stock (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
$0.90
Daily low
$0.85
Price at open
$0.87
52 Week High
$3.23
52 Week Low
$0.63
Market cap
31.8M
Dividend yield
0.00%
Volume
32
Avg. volume
61,905
P/E ratio
-3.62
Estrella Immunopharma, Inc. - Common Stock News
Details
Daily high
$0.90
Daily low
$0.85
Price at open
$0.87
52 Week High
$3.23
52 Week Low
$0.63
Market cap
31.8M
Dividend yield
0.00%
Volume
32
Avg. volume
61,905
P/E ratio
-3.62